Exact Mass: 452.2303
Exact Mass Matches: 452.2303
Found 309 metabolites which its exact mass value is equals to given mass value 452.2303
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Bisbenzimide
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D020011 - Protective Agents > D011837 - Radiation-Protective Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes D011838 - Radiation-Sensitizing Agents Bisbenzimide. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=23491-52-3 (retrieved 2024-08-14) (CAS RN: 23491-52-3). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
Tafluprost
Tafluprost is only found in individuals that have used or taken this drug. It is a prostaglandin analogue used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension. Tafluprost was approved for use in the U.S. on February 10, 2012.Tafluprost is a prostaglandin F2a analogue. Specifically, Tafluprost is a prostanoid selective FP receptor agonist that is believed to reduce the intraocular pressure (IOP) by increasing the outflow of aqueous humor. Studies in animals and man suggest that the main mechanism of action is increased uveoscleral outflow. S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics > S01EE - Prostaglandin analogues C78568 - Prostaglandin Analogue
Delapril
(S)-3-(8-(Dimethylaminomethyl)-6,7,8,9-tetrahydropyrido(1,2-a)indol-10-yl)-4-(1-methyl-3-indolyl)-1H-pyrrole-2,5-dione hydrochloride
(R)-Oct-1-en-3-yl O-??-L-arabinopyranosyl-(1鈥樏傗垎6)-??-D-glucopyranoside
Ala Ile Ser Tyr
Ala Ile Tyr Ser
Ala Leu Ser Tyr
Ala Leu Tyr Ser
Ala Ser Ile Tyr
Ala Ser Leu Tyr
Ala Ser Tyr Ile
Ala Ser Tyr Leu
Ala Thr Val Tyr
Ala Thr Tyr Val
Ala Val Thr Tyr
Ala Val Tyr Thr
Ala Tyr Ile Ser
Ala Tyr Leu Ser
Ala Tyr Ser Ile
Ala Tyr Ser Leu
Ala Tyr Thr Val
Ala Tyr Val Thr
Phe Ile Ser Ser
Phe Leu Ser Ser
Phe Ser Ile Ser
Phe Ser Leu Ser
Phe Ser Ser Ile
Phe Ser Ser Leu
Phe Ser Thr Val
Phe Ser Val Thr
Phe Thr Ser Val
Phe Thr Val Ser
Phe Val Ser Thr
Phe Val Thr Ser
Gly Ile Thr Tyr
Gly Ile Tyr Thr
Gly Leu Thr Tyr
Gly Leu Tyr Thr
Gly Thr Ile Tyr
Gly Thr Leu Tyr
Gly Thr Tyr Ile
Gly Thr Tyr Leu
Gly Tyr Ile Thr
Gly Tyr Leu Thr
Gly Tyr Thr Ile
Gly Tyr Thr Leu
His Ile Pro Ser
His Ile Ser Pro
His Leu Pro Ser
His Leu Ser Pro
His Pro Ile Ser
His Pro Leu Ser
His Pro Ser Ile
His Pro Ser Leu
His Pro Thr Val
His Pro Val Thr
His Ser Ile Pro
His Ser Leu Pro
His Ser Pro Ile
His Ser Pro Leu
His Thr Pro Val
His Thr Val Pro
His Val Pro Thr
His Val Thr Pro
Ile Ala Ser Tyr
Ile Ala Tyr Ser
Ile Phe Ser Ser
Ile Gly Thr Tyr
Ile Gly Tyr Thr
Ile His Pro Ser
Ile His Ser Pro
Ile Pro His Ser
Ile Pro Ser His
Ile Ser Ala Tyr
Ile Ser Phe Ser
Ile Ser His Pro
Ile Ser Pro His
Ile Ser Ser Phe
Ile Ser Tyr Ala
Ile Thr Gly Tyr
Ile Thr Tyr Gly
Ile Tyr Ala Ser
Ile Tyr Gly Thr
Ile Tyr Ser Ala
Ile Tyr Thr Gly
Leu Ala Ser Tyr
Leu Ala Tyr Ser
Leu Phe Ser Ser
Leu Gly Thr Tyr
Leu Gly Tyr Thr
Leu His Pro Ser
Leu His Ser Pro
Leu Pro His Ser
Leu Pro Ser His
Leu Ser Ala Tyr
Leu Ser Phe Ser
Leu Ser His Pro
Leu Ser Pro His
Leu Ser Ser Phe
Leu Ser Tyr Ala
Leu Thr Gly Tyr
Leu Thr Tyr Gly
Leu Tyr Ala Ser
Leu Tyr Gly Thr
Leu Tyr Ser Ala
Leu Tyr Thr Gly
Pro His Ile Ser
Pro His Leu Ser
Pro His Ser Ile
Pro His Ser Leu
Pro His Thr Val
Pro His Val Thr
Pro Ile His Ser
Pro Ile Ser His
Pro Leu His Ser
Pro Leu Ser His
Pro Ser His Ile
Pro Ser His Leu
Pro Ser Ile His
Pro Ser Leu His
Pro Thr His Val
Pro Thr Val His
Pro Val His Thr
Pro Val Thr His
Ser Ala Ile Tyr
Ser Ala Leu Tyr
Ser Ala Tyr Ile
Ser Ala Tyr Leu
Ser Phe Ile Ser
Ser Phe Leu Ser
Ser Phe Ser Ile
Ser Phe Ser Leu
Ser Phe Thr Val
Ser Phe Val Thr
Ser His Ile Pro
Ser His Leu Pro
Ser His Pro Ile
Ser His Pro Leu
Ser Ile Ala Tyr
Ser Ile Phe Ser
Ser Ile His Pro
Ser Ile Pro His
Ser Ile Ser Phe
Ser Ile Tyr Ala
Ser Leu Ala Tyr
Ser Leu Phe Ser
Ser Leu His Pro
Ser Leu Pro His
Ser Leu Ser Phe
Ser Leu Tyr Ala
Ser Pro His Ile
Ser Pro His Leu
Ser Pro Ile His
Ser Pro Leu His
Ser Ser Phe Ile
Ser Ser Phe Leu
Ser Ser Ile Phe
Ser Ser Leu Phe
Ser Thr Phe Val
Ser Thr Val Phe
Ser Val Phe Thr
Ser Val Thr Phe
Ser Tyr Ala Ile
Ser Tyr Ala Leu
Ser Tyr Ile Ala
Ser Tyr Leu Ala
Thr Ala Val Tyr
Thr Ala Tyr Val
Thr Phe Ser Val
Thr Phe Val Ser
Thr Gly Ile Tyr
Thr Gly Leu Tyr
Thr Gly Tyr Ile
Thr Gly Tyr Leu
Thr His Pro Val
Thr His Val Pro
Thr Ile Gly Tyr
Thr Ile Tyr Gly
Thr Leu Gly Tyr
Thr Leu Tyr Gly
Thr Pro His Val
Thr Pro Val His
Thr Ser Phe Val
Thr Ser Val Phe
Thr Val Ala Tyr
Thr Val Phe Ser
Thr Val His Pro
Thr Val Pro His
Thr Val Ser Phe
Thr Val Tyr Ala
Thr Tyr Ala Val
Thr Tyr Gly Ile
Thr Tyr Gly Leu
Thr Tyr Ile Gly
Thr Tyr Leu Gly
Thr Tyr Val Ala
Val Ala Thr Tyr
Val Ala Tyr Thr
Val Phe Ser Thr
Val Phe Thr Ser
Val His Pro Thr
Val His Thr Pro
Val Pro His Thr
Val Pro Thr His
Val Ser Phe Thr
Val Ser Thr Phe
Val Thr Ala Tyr
Val Thr Phe Ser
Val Thr His Pro
Val Thr Pro His
Val Thr Ser Phe
Val Thr Tyr Ala
Val Tyr Ala Thr
Val Tyr Thr Ala
Tyr Ala Ile Ser
Tyr Ala Leu Ser
Tyr Ala Ser Ile
Tyr Ala Ser Leu
Tyr Ala Thr Val
Tyr Ala Val Thr
Tyr Gly Ile Thr
Tyr Gly Leu Thr
Tyr Gly Thr Ile
Tyr Gly Thr Leu
Tyr Ile Ala Ser
Tyr Ile Gly Thr
Tyr Ile Ser Ala
Tyr Ile Thr Gly
Tyr Leu Ala Ser
Tyr Leu Gly Thr
Tyr Leu Ser Ala
Tyr Leu Thr Gly
Tyr Ser Ala Ile
Tyr Ser Ala Leu
Tyr Ser Ile Ala
Tyr Ser Leu Ala
Tyr Thr Ala Val
Tyr Thr Gly Ile
Tyr Thr Gly Leu
Tyr Thr Ile Gly
Tyr Thr Leu Gly
Tyr Thr Val Ala
Tyr Val Ala Thr
Tyr Val Thr Ala
Tafluprost
S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics > S01EE - Prostaglandin analogues C78568 - Prostaglandin Analogue
Delapril
C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09A - Ace inhibitors, plain > C09AA - Ace inhibitors, plain D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
tert-Butyl-{3-[2-(diphenyl-phosphinoyl)-ethylidene]-4-methylene-cyclohexyloxy}-dimethyl-silane
Dexamethasone Acetate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents
3-(8-((Dimethylamino)methyl)-6,7,8,9-tetrahydropyrido(1,2-a)indol-10-yl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione
1-Benzyl-2,3-dimethylguanidinium sulphate (2:1)
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents
Bethanidine Sulfate
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents
bis{N-[(benzylamino)(methylamino)methylidene]methanaminium} sulfate
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents
[2-Methoxy-5-[[4-(4-methylphenyl)-1-phthalazinyl]amino]phenyl]-(1-piperidinyl)methanone
(2R,3R,3aS,9bS)-1-(cyclopentylmethyl)-3-(hydroxymethyl)-7-(2-methoxyphenyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylic acid methyl ester
(2S,3S,3aR,9bR)-1-(cyclopentylmethyl)-3-(hydroxymethyl)-7-(2-methoxyphenyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylic acid methyl ester
(1R)-N-(2-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]carboxamide
[4-[Hydroxy(diphenyl)methyl]-1-triazolyl]-[4-(phenylmethyl)-1-piperidinyl]methanone
Bisbenzimide
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D020011 - Protective Agents > D011837 - Radiation-Protective Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes D011838 - Radiation-Sensitizing Agents
KT172
KT172 is a DAGLβ inhibitor with an IC50 value of 11 nM. KT172 can be used for the research of metabolic and inflammatory[1].